Skip to content
AwardedPRTGoods€348,000

251G001445 - INFLIXIMAB 100 MG INJ BIOSSIMILAR (ZESSL)

Published
Published 11 November 2025

Overview

INFLIXIMAB 100 MG INJ BIOSSIMILAR (ZESSL

Key details

Country
PRT
Status
Awarded
Category
Goods
Estimated value
€348,000
Procedure
Selective
Published
11 November 2025
Classification (CPV)
Antineoplastic and immunomodulating agents

Award outcome

Awarded value
€348,000
Award date
14 October 2025
Contract period
— → 12 January 2026
Winner
  • SANDOZ FARMACEUTICA, LDA

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    11 November 2025

Contracting authority

  • Unidade Local de Saúde Santa Maria, E.P.E.

    Procuring entity

    Lisboa, PRT

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: 251G001445 - INFLIXIMAB 100 MG INJ BIOSSIMILAR (ZESSL) — won by SANDOZ FARMACEUTICA, LDA — Skim